MiMedx amends bylaws to allow CEO to serve on up to three public boards; shareholders re-elect seven directors

MIMEDX GROUP, INC.

Bylaw amendment increases CEO's permissible public-company board seats from two to three.
Shareholders re-elected Joseph H. Capper, James L. Bierman, William A. Hawkins, III, K. Todd Newton, Tiffany Olson, Dorothy Puhy, and Martin P. Sutter.
Advisory vote on executive compensation approved with 95.2M for, 4.4M against, 2.2M abstain.
Ratification of Deloitte & Touche as independent auditor for FY2026 approved with 123.7M votes for.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MIMEDX GROUP, INC.: Increased the number of boards of directors of public companies that the Company's chief executive officer may sit on to three (effective 2026-06-10).

Change: bylaw amendment
Effective: 2026-06-10

Exact text from the filing

On June 10, 2026, the Board of Directors of MiMedx Group, Inc. (the “ Company ”) approved an amendment to the Company’s Amended & Restated Bylaws. The amendment increased the number of boards of directors of public companies that the Company’s chief executive officer may sit on to three.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

MIMEDX GROUP, INC. shareholders approved Election of Nine Directors at the 2026-06-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Proposal 1: Election of Nine Directors. For Against Abstain Broker Non-Votes Joseph H. Capper 99,286,347 2,395,447 70,158 23,609,013 James L. Bierman 96,181,316 5,500,069 70,567 23,609,013 William A. Hawkins, III 98,237,248 3,417,906 96,798 23,609,013 K. Todd Newton 96,493,668 5,219,808 38,476 23,609,013 Tiffany Olson 98,657,185 2,984,080 110,687 23,609,013 Dorothy Puhy 98,645,942 2,993,132 112,878 23,609,013 Martin P. Sutter 97,032,156 4,617,992 101,804 23,609,013

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

MIMEDX GROUP, INC. shareholders approved Advisory approval of executive compensation at the 2026-06-10 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Proposal 2: Advisory approval of executive compensation. For Against Abstain Broker Non-Votes Total Shares Voted 95,158,451 4,369,645 2,223,856 23,609,013

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

MIMEDX GROUP, INC. shareholders approved Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Proposal 3: Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes Total Shares Voted 123,687,080 1,640,474 33,411 N/A

View on SEC.gov

255 governance changes filed in the last 30 days. Browse all governance changes →

MIMEDX GROUP, INC. filing history →

Source: SEC EDGAR

accession 0001376339-26-000052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.